169905-10-6 Usage
General Description
2-CHLOROMETHYL-3,4-DIMETHOXY PYRIDINE HYDROCHLORIDE is a chemical compound that is used in the pharmaceutical industry for its potential medicinal properties. It contains a chloromethyl functional group and two dimethoxy groups attached to a pyridine ring. It is commonly used as a reagent in organic synthesis and is also being studied for its potential as a drug target in the treatment of various diseases. 2-CHLOROMETHYL-3,4-DIMETHOXY PYRIDINE HYDROCHLORIDE has been shown to possess antimicrobial and antiviral properties, and it is being explored for its potential use in the development of new pharmaceutical drugs. Its hydrochloride form is a stable and easily handled solid, making it suitable for use in laboratory and industrial settings.
Check Digit Verification of cas no
The CAS Registry Mumber 169905-10-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,9,0 and 5 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 169905-10:
(8*1)+(7*6)+(6*9)+(5*9)+(4*0)+(3*5)+(2*1)+(1*0)=166
166 % 10 = 6
So 169905-10-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H10ClNO2/c1-11-7-3-4-10-6(5-9)8(7)12-2/h3-4H,5H2,1-2H3
169905-10-6Relevant articles and documents
A practical one pot synthesis of 2-[2-(pridylmethyl)-thio]-1H-benzimidazoles
Rane,Pathak,Kaushik,Prasad Rao,Kumar, Ashok
, p. 1211 - 1217 (2007/10/03)
A combination of Et3N and pTSCl was found to be far superior than pTSCl or benzene sulfonyl chloride alone in convert ing substituted 2-picoline-N-oxides to the corresponding 2-chloromethylpyridines and has been exploited for the synthesis of a variety of 2-[2-(pyridylmethyl)-thio]-1H-benzimidazoles, key intermediates in the manufacture of H+/K+-ATPase inhibitors in a single pot.
Therapeutically active chloro substituted benzimidazole
-
, (2008/06/13)
5-Chloro-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole and physiologically acceptable salts thereof as well as an intermediate, pharmaceutical compositions containing such compound as active ingredient, and the use of the compound in medicine.